Scopus by Title (Ref)

Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis

International Journal of Molecular Sciences

May 2024

Fellhofer-Hofer J.

Open Access

Tranilast attenuates lipopolysaccharide-induced lung injury via the CXCR4/JAK2/STAT3 signaling pathway

Molecular Medicine Reports

July 2022

Lou Y.

Open Access

CXCL12-CXCR4 axis: its role and the drug inhibitors on each type of cancers

World Cancer Research Journal

2022

Zarinkhat A.

Review Insights In Cardiac Tissue Engineering: Cells, Scaffolds and Pharmacological Agents

Iranian Journal of Pharmaceutical Research

October 2021

Boroumand S.

In vitro analysis of the combinatory effects of novel aminonaphthoquinone derivatives and curcumin on breast cancer progression

Anticancer Research

2020

Pereira M.C.

Open Access

Tranilast enhances the effect of anticancer agents in osteosarcoma

Oncology Reports

July 2019

Nakashima T.

Open Access

Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor

Journal of Gastroenterology

1 February 2018

Shiozaki A.

L-arginine alters the effect of 5-fluorouracil on breast cancer cells in favor of apoptosis

Biomedicine and Pharmacotherapy

1 April 2017

Jahani M.

Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis

Tumor Biology

1 January 2017

Li Y.P.

Open Access

Finding New Tricks for Old Drugs: Tumoricidal Activity of Non-Traditional Antitumor Drugs

AAPS Pharmscitech

1 June 2016

Zhang F.

New function of TSGA10 gene in angiogenesis and tumor metastasis: A response to a challengeable paradox

Human Molecular Genetics

15 January 2016

Mansouri K.

Open Access

CD105 promotes hepatocarcinoma cell invasion and metastasis through VEGF

Tumor Biology

27 February 2015

Li Y.

Tranilast: A review of its therapeutic applications

Pharmacological Research

January 2015

Darakhshan S.